The global pharmaceutical company, GlaxoSmithKline (GSK) have announced that they will be cutting 380 pharmaceutical jobs at their site in Harlow, Essex. The site currently employs 1,150 staff. The cuts come as projects for pain relief, anxiety and depression drugs come to an end. Despite reporting an annual rise in profits of 12% earlier this year, the pharma company are still stressing the need to make cost savings.
GSK’s CEO, Andrew Witty stated that “Glaxo would discontinue research in some areas including depression and pain, and would focus more on degenerative and inflammatory diseases such as Alzheimer’s disease and Parkinson’s disease.”
Glaxo has its headquarters in Brentford, Middlesex, and research bases at Stevenage and Ware in Hertfordshire and Harlow in Essex.
Worried about redundancy? Search for Pharmaceutical Jobs in the UK now.